Antibody recognizing N-domain of midkine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9624294
SERIAL NO

14004548

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to isolated or recombinant proteins, such as antibodies, which inhibit or reduce the function of midkine (hereinafter, referred to as “MK”) for use in the treatment or prevention of midkine-related disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CELLMID LIMITEDSYDNEY NSW 2000

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Halasz, Maria Sydney, AU 7 5
Jones, Darren Avalon, AU 84 993
Sakuma, Sadatosi Kanagawa, JP 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 18, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00